Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date August 15, 2024
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) — At the end of the settlement date of August 15, 2024, short […]
ClearPoint Neuro Announces Early Repayment of $10 Million Note
SOLANA BEACH, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, […]
Leslie’s, Inc. Announces CEO Transition
Jason McDonell Appointed CEO; Joining Company on September 9, 2024 Mike Egeck Departs Leslie’s; Chairman John Strain to Serve as […]
Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales
DUBLIN, Ireland, Aug. 26, 2024 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human […]
LifeVantage Welcomes Rajendran Anbalagan to the Board of Directors; Thanks Erin Brockovich for Her Years of Service
SALT LAKE CITY, Aug. 26, 2024 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with […]
Notable Labs Announces CEO Transition
Thomas Bock, MD resigns as CEO; Joseph Wagner, PhD, CSO, appointed interim CEO Company affirms plan to initiate volasertib Phase […]
Varonis to Present at Upcoming Investor Conference
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) — Varonis Systems, Inc. (Nasdaq: VRNS), a leader in data security, announced its […]
Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference
MIAMI, Aug. 26, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular […]
Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer
SEATTLE, Aug. 26, 2024 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for […]
Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal Administration of Bel-sar for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma at The Retina Society Annual Meeting
BOSTON, Aug. 26, 2024 (GLOBE NEWSWIRE) — Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies to […]
